BlueCross BlueShield of South Carolina (BCBS-SC) issued a positive commercial payor policy covering Paradigm Spine’s coflex® Interlaminar Stabilization® device to treat lumbar spinal stenosis. The policy, titled “Interspinous and Interlaminar Stabilization/Distraction Devices (Spacers),” is dated August 2018.
BCBS-SC is the largest commercial payor in South Carolina, significantly expanding coflex’s patient access.
Other coflex announcements in 2018 include:
- In May, NASS issued a policy recommendation for Lumbar Interlaminar Device without Fusion and with Decompression, providing private payors with evidence to allow access for the coflex technology.
- Also in May, the coflex Interlaminar Stabilization disposable instrument kit became the first approved disposable spinal instrument set for a Class III spinal device to receive a supplemental FDA PMA.
- Paradigm Spine announced positive two-year coflex study results in January.
Sources: Paradigm Spine; ORTHOWORLD, Inc.